Dengue virus serotype 1 non-structural protein NS5 expression interferes with HIV replication in a CD4+ T-cell line.

Am J Trop Med Hyg

Faculty of Medicine, University of Colima, Colima, Mexico; Center for Biomedical Research, University of Colima, Colima, Mexico; Department of Emerging Diseases and Emergencies, Institute for Epidemiological Diagnosis and Reference, Mexico City, Mexico.

Published: March 2014

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945685PMC
http://dx.doi.org/10.4269/ajtmh.12-0660DOI Listing

Publication Analysis

Top Keywords

dengue virus
4
virus serotype
4
serotype non-structural
4
non-structural protein
4
protein ns5
4
ns5 expression
4
expression interferes
4
interferes hiv
4
hiv replication
4
replication cd4+
4

Similar Publications

Embryonic dormancy in Aedes aegypti and Aedes albopictus (Diptera: Culicidae): a survival and dispersal mechanism.

J Vector Borne Dis

October 2024

Programa de Pós-Graduação em Microbiologia, Parasitologia e Patologia, Departamento de Patologia, Laboratório de Parasitologia Molecular, Universidade Federal do Paraná (UFPR), Curitiba, Paraná, Brasil.

Aedes aegypti and Aedes albopictus are the main vectors of arboviruses such as dengue, Zika virus, and chikungunya. Ae. aegypti is a widely spread mosquito in tropical and subtropical regions, whereas Ae.

View Article and Find Full Text PDF

Flaviviruses, which include globally impactful pathogens, such as West Nile virus, yellow fever virus, Zika virus, Japanese encephalitis virus, and dengue virus, contribute significantly to human infections. Despite the ongoing emergence and resurgence of flavivirus-mediated pathogenesis, the absence of specific therapeutic options remains a challenge in the prevention and treatment of flaviviral infections. Through the intricate processes of fusion, transcription, replication, and maturation, the complex interplay of viral and host metabolic interactions affects pathophysiology.

View Article and Find Full Text PDF

[Targets and mechanisms of neutralizing monoclonal antibodies against Dengue virus].

Sheng Wu Gong Cheng Xue Bao

December 2024

CAS Key Laboratory of Pathogenic Microbiology & Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

Dengue fever is a mosquito-borne disease prevalent in tropical and subtropical regions, with its prevalence expanding due to increased global travel. The dengue virus, the causative agent of dengue fever, often co-circulates in the form of four distinct serotypes. Cross-reactive antibodies generated during a primary infection pose a significant risk during secondary infections with different serotypes, and fully protective vaccines and antiviral drugs are yet to be developed.

View Article and Find Full Text PDF

Rapid human movement and dengue transmission in Bangladesh: a spatial and temporal analysis based on different policy measures of COVID-19 pandemic and Eid festival.

Infect Dis Poverty

December 2024

Ecosystem Change and Population Health Research Group, Centre for Immunology and Infection Control, School of Public Health and Social Work, Queensland University of Technology, Kelvin Grove, Brisbane, QLD, 4059, Australia.

Background: Rapid human movement plays a crucial role in the spatial dissemination of the dengue virus. Nevertheless, robust quantification of this relationship using both spatial and temporal models remains necessary. This study aims to explore the spatial and temporal patterns of dengue transmission under various human movement contexts.

View Article and Find Full Text PDF

Predicting the infecting dengue serotype from antibody titre data using machine learning.

PLoS Comput Biol

December 2024

MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, United Kingdom.

The development of a safe and efficacious vaccine that provides immunity against all four dengue virus serotypes is a priority, and a significant challenge for vaccine development has been defining and measuring serotype-specific outcomes and correlates of protection. The plaque reduction neutralisation test (PRNT) is the gold standard assay for measuring serotype-specific antibodies, but this test cannot differentiate homotypic and heterotypic antibodies and characterising the infection history is challenging. To address this, we present an analysis of pre- and post-infection antibody titres measured using the PRNT, collected from a prospective cohort of Thai children.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!